The impact of HIV on sub-Saharan African eye departments [35]

Eye

Volumn 20, Issue 12, 2006, Pages 1414-1415

  Beare, N A V ^a   Batumba, N H ^a  

^a UNIVERSITY OF MALAWI   (Malawi)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AFRICA; CONJUNCTIVA TUMOR; DISEASE ASSOCIATION; DISEASE SEVERITY; EPIDEMIC; EYE CARE; EYE INFECTION; HERPES ZOSTER; HIGH RISK PATIENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; MORBIDITY; RECURRENT DISEASE; RISK ASSESSMENT; SQUAMOUS CELL CARCINOMA; SUPERINFECTION; VERRUCA VULGARIS; WART VIRUS;

EID: 33845539348     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/sj.eye.6702271     Document Type: Letter

References (4)

1. Evans BG. Management of blinding disease: Loss of immunity and superinfection. Eye 2005; 19: 1035-1036.
2. Newton R, Ziegler J, Ateenyi-Agaba C, Bousarghin L, Casabonne D, Beral V et al. The epidemiology of conjunctival squamous cell carcinoma in Uganda. Br J Cancer 2002; 87: 301-308.
3. Waddell KM, Lewallen S, Lucas SB, Atenyi-Agaba C, Herrington CS, Liomba G. Carcinoma of the conjunctiva and HIV infection in Uganda and Malawi. Br J Ophthalmol 1996; 80: 503-508.
4. Ministry of Health and Population, Malawi. Treatment of AIDS; guidlines for the use of antiretroviral therapy in Malawi. Ist edn. 2003.